Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults—cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Environment International
- Vol. 137, 105573
Abstract
No abstract availableKeywords
Funding Information
- US National Institute of Environmental Health Sciences
- National Institutes of Health (R01ES024765)
This publication has 52 references indexed in Scilit:
- No association between perfluoroalkyl chemicals and hypertension in childrenIntegrated Blood Pressure Control, 2014
- Association between Plasma PFOA and PFOS Levels and Total Cholesterol in a Middle-Aged Danish PopulationPLOS ONE, 2013
- Do perfluoroalkyl substances affect metabolic function and plasma lipids?—Analysis of the 2007–2009, Canadian Health Measures Survey (CHMS) Cycle 1Environmental Research, 2013
- Perfluorooctanoic acid exposure is associated with elevated homocysteine and hypertension in US adultsOccupational and Environmental Medicine, 2012
- Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA)Environmental Health Perspectives, 2010
- Association between Serum Perfluorooctanoic Acid (PFOA) and Thyroid Disease in the U.S. National Health and Nutrition Examination SurveyEnvironmental Health Perspectives, 2010
- Perfluorooctane Sulfonate (PFOS) Induces Reactive Oxygen Species (ROS) Production in Human Microvascular Endothelial Cells: Role in Endothelial PermeabilityJournal of Toxicology and Environmental Health, Part A, 2010
- Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight, and Insulin Resistance in the General U.S. PopulationEnvironmental Health Perspectives, 2010
- Adjusting for treatment effects in studies of quantitative traits: antihypertensive therapy and systolic blood pressureStatistics in Medicine, 2005
- Checking the Cox model with cumulative sums of martingale-based residualsBiometrika, 1993